Quicksilver Scientific partnered with Truss CBD USA, which is a joint venture between Molson Coors and HEXO Cannabis. Quicksilver will provide their patent-pending nanoemulsion delivery technology for use in Veryvell, Truss’s new US line of non-alcoholic, hemp-derived CBD beverages.
The Veryvell line is designed as an alternative to alcohol, so the team designed products to have a very fast cannabinoid absorption, uptake and offset from the system, mirroring the experience of consuming an alcoholic beverage.
Quicksilver Scientific applied its experience developing nutraceutical protocols to contribute to Veryvell’s three formulations, each intended to deliver an entourage of distinctive benefits. The three blends include „Focus” (grapefruit and tarragon with ginseng and guarana), „Mind & Body” (strawberry and hibiscus with ashwagandha and elderberry) and „Unwind” (blueberry and lavender flavors with ashwagandha and L-Theanine).
A force to be reckoned with
“Delivery technologies are going to be a huge, disruptive force in the US cannabis beverage market and Quicksilver Scientific is on the forefront, with the most advanced, efficacious, patent-pending delivery technology,” said David Durkee, vice president of new ventures, Quicksilver Scientific.
“In addition, disruption is not only about using the best emulsion, but also pairing it with the most sophisticated beverage making techniques, which is where Molson Coors shines. Coupling our advanced delivery technology with their product manufacturing expertise is a transformative shift in the CBD beverage industry,” Durkee added, who came to Quicksilver from Molson Coors, where he spent nearly ten years in a wide range of roles, including global product development.